2-(Ethylamino)-1,2-diphenylethanone

2-(Ethylamino)-1,2-diphenylethanone (also known as [alpha-(Ethylamino)benzyl]-(phenyl)-ketone and βk-Ephenidine) is a chemical compound invented by AstraZeneca which is claimed as an inhibitor of the enzyme 11β-Hydroxysteroid dehydrogenase type 1.[1] No other pharmacological data has been disclosed, though its chemical structure closely resembles that of certain designer drug compounds such as ephenidine and N-ethylhexedrone.

2-(Ethylamino)-1,2-diphenylethanone

Clinical data
ATC code	None
Identifiers
IUPAC name 2-(ethylamino)-1,2-diphenylethanone
PubChem CID	69702363
Chemical and physical data
Formula	C16H17NO
Molar mass	239.318 g·mol−1
3D model (JSmol)	Interactive image
SMILES CCNC(C1=CC=CC=C1)C(=O)C2=CC=CC=C2
InChI InChI=1S/C16H17NO/c1-2-17-15(13-9-5-3-6-10-13)16(18)14-11-7-4-8-12-14/h3-12,15,17H,2H2,1H3 Key:NHNVMSYWZNJBOO-UHFFFAOYSA-N